Inactive Instrument

Qlife Holding AB (publ) Share Price Nasdaq Stockholm

Equities

SE0013486552

Medical Equipment, Supplies & Distribution

Financials

Sales 2023 244K 22.19K 1.77M Sales 2024 * 3M 273K 21.8M Capitalization 1.94M 176K 14.07M
Net income 2023 * - Net income 2024 * - EV / Sales 2023 103 x
Net cash position 2023 12.39M 1.13M 90.02M Net cash position 2024 * - 0 0 EV / Sales 2024 * 0.65 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 61.84%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Founder 57 31/12/18
Founder 57 10/10/19
Director of Finance/CFO 58 10-31
Members of the board TitleAgeSince
Founder 57 10/10/19
Chairman 71 31/12/22
Director/Board Member 50 31/12/22
More insiders
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Calendar
More about the company